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Vernier acuity measures the ability to detect a misalignment or positional offset between
visual stimuli, for example between two vertical lines when reading a vernier scale.
It is considered a form of visual hyperacuity due to its detectable thresholds being
considerably smaller than the diameter of a foveal cone receptor, which limits the spatial
resolution of classical visual acuity. Vernier acuity relies heavily on cortical processing
and is minimally affected by optical media factors, making it a useful indicator of cortical
visual function. Vernier acuity can be measured, usually in seconds of arc, by freely
available automated online tools as well as via analysis of steady state visual-evoked
potentials, which allows measurement in non- or pre-verbal subjects such as infants.
Although not routinely measured in clinical practice, vernier acuity is known to be
reduced in amblyopia, glaucoma and retinitis pigmentosa, and has been explored as
a measure of retinal or neural visual function in the presence of optical media opacities.
Current clinical utility includes a home-based vernier acuity tool, preferential hyperacuity
perimetry, which is used for screening for choroidal neovascularisation in age-related
macular degeneration. This review will discuss the measurement of vernier acuity,
provide a current understanding of its neuro-ophthalmic mechanisms, and finally explore
its utility through a clinical lens, along with our recommendations for best practice.
Keywords: vernier acuity, hyperacuity, positional acuity, alignment acuity, vernier alignment, vision, visual
function
INTRODUCTION
The vernier scale, invented in 1631 by the French mathematician Pierre Vernier, allows very precise
measurement of length and is read by distinguishing aligned from misaligned vertical lines between
adjacent scales (Figure 1). This essentially requires the user to perform a vernier acuity task: to
detect small offsets in the alignment between visual objects, in a direction perpendicular to a line
joining the objects.
The vernier threshold (smallest detectable offset) for humans is as low as 2 to 5 arcseconds
(Westheimer and McKee, 1977b; Westheimer, 1987). Vernier acuity is hence regarded as a type of
hyperacuity (Westheimer, 1975), a term that describes visual tasks that have thresholds smaller than
the size of a foveal cone (2.5 µm, about 30 s of arc), which limits the classical spatial resolution of the
eye. Other examples include stereoscopic acuity (binocular vision), line orientation discrimination,
and detection of curvature (Westheimer, 1981).
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FIGURE 1 | Vernier calliper with a vernier scale on the sliding secondary scale.
On the vernier scale the zero line provides the reading before the decimal
point (12 mm), while the non-zero line (3) that aligns most closely with a line
on the major scale provides the reading after the decimal place. This totals a
measurement of 12.3 mm.
Vernier acuity is a fascinating and important measure of
visual function – particularly cortical visual function – but
is infrequently used in clinical practice because it is not
well understood. Vernier acuity thresholds can be measured
with software that is freely available online with as little
equipment as a computer. More complex measurement can
be carried out using visual evoked potentials, which require
more sophisticated equipment and analysis. Vernier related
visual tasks are generally easy for subjects to understand and
perform. Measurement of vernier acuity can provide a diagnostic
tool that tests a unique aspect of human perception. It has
previously been studied in visual disorders such as age-related
macular degeneration, glaucoma, and amblyopia. Given its
psychophysical characteristics, vernier acuity may also be a useful
outcome measure in clinical trials of emerging neuro-ophthalmic
treatments, and be useful for more defined diagnostic protocols.
This review aims to bring together broad information on
vernier acuity from a clinical perspective, with the purpose
of providing guidance on its utility in clinical settings and
factors to consider for measuring vernier acuity robustly in a
standardised way.
MEASUREMENT OF VERNIER ACUITY
Several methods for the measurement of vernier acuity are
reported in the literature. Vernier offsets can be detected from
stimuli including dots, lines, and gratings (Figure 2), which are
usually displayed on a computer screen. Features including the
background contrast, luminance, gap size between objects and
object sizes can be varied. Psychophysical methods for measuring
vernier thresholds rely on behavioural responses based on the
judgement of the observer (their visual perception) when viewing
the relative positions of these objects. A lower vernier threshold
represents better vernier acuity. For example, in a two-alternative,
forced-choice (2AFC) paradigm, the observer may be instructed
to indicate whether the upper object is offset to the left or the
right of the lower reference object. In a three-alternative forced-
choice (3AFC) paradigm, the observer may be instructed to
distinguish one object-pair that is misaligned (i.e., containing
a vernier offset) from two other object-pairs that are aligned
(Li et al., 2012). The observer’s response for each trial can be
input by either the observer or the examiner. It is thought to be
beneficial to give feedback for correct/incorrect responses, so as
to maintain the subject’s interest in the task (Enoch et al., 1985).
To minimise the effect of perceptual learning, participants can
carry out pretraining (Duncan and Boynton, 2003).
Determination of the threshold depends on the method used.
When measuring using a staircase procedure, the vernier offset
magnitude between stimuli is larger to begin with and is reduced
when the observer makes a certain number of correct responses
or increased for incorrect responses. Researchers must choose
a percentage level of correct responses at which to define the
vernier threshold. This level can range from 66 to 85.4% (Enoch
et al., 1984b; Li et al., 2012). The number of trials required to
complete a staircase can vary from as few as 20 to over 100 (Enoch
et al., 1984a; Li et al., 2012), depending on the algorithm used,
with 25 trials taking around 3–4 min to complete (Enoch et al.,
1985). Another approach reported in the literature is the method
of constant stimuli, where stimuli of varying vernier offset size
are presented in a random order and the frequency-of-seeing
against offset size (psychometric curve) plotted to determine the
threshold at a prespecified cut-off (Levi et al., 2000; Li et al.,
2000). A constant stimuli procedure involving 300 or more trials
was reported to require 20–30 min in experienced observers
(Westheimer and McKee, 1977b), although participants in a
more recent study only required 2–5 min to complete 105 trials
(Latham et al., 2013). Another strategy that can be used is
the adjustment method, where the participant must manually
position an object on a screen so that it is aligned with one or two
other reference objects. In a study with untrained observers using
this method, 10 trials were reported to take around 5 min, but
due to interindividual variability, the number of trials required to
measure a mean vernier threshold with a 10% confidence interval
was 100–700 trials (Abbud and Cruz, 2002).
Several key open source computer software programs for
the psychophysical measurement of vernier acuity are available
online. The vernier acuity module of the Freiburg Acuity Test
(FrACT) software1 includes an automatic 2AFC staircase with
the BestPEST adaptive algorithm on the direction (left or right)
of horizontal offset between the position of two vertical lines.
The FrACT has been well validated and established in the
measurement of acuity in low vision patients (Lange et al., 2009;
Jolly et al., 2019). The vernier acuity module provides a valuable
adjunct in the battery available. The Psychophysics Toolbox2 can
be run on Matlab or Octave to display vernier targets and measure
vernier thresholds; Psychopy3 is a Python-based package that
offers similar functions.
Steady state visual evoked potentials (VEPs) can be used
as an objective measure of vernier acuity and so are useful
in pre-verbal or non-verbal participants, including infants.
Electroencephalogram electrodes are placed on the observer’s
scalp over the occipital pole [positions OZ, O1, O2; reference
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FIGURE 2 | (A) Vernier stimuli can consist of pairs of discrete dot-like shapes, lines or other juxtaposed elements where an offset occurs in a direction perpendicular
to a line joining the features of interest. (B) When measuring vernier acuity with steady state visual evoked potentials, animations that transition between aligned and
misaligned stimuli are used. (C) Preferential hyperacuity perimetry requires the subject to identify misaligned dots on a computer screen.
onset/offset animated grating pattern (Figure 2B) is shown to
the observer while VEPs are recorded. Spectral analysis of the
response demonstrates two components: the odd harmonics
of the stimulus frequency (first, third. . .) correspond to the
vernier displacement magnitude, while the even harmonics
(second, fourth. . .) correspond to the motion of the stimulus
(Norcia et al., 1999). Plotting the amplitude of the first (1F)
harmonic response against the log displacement magnitude
yields an approximately linear relationship, and extrapolation
of the regression line to a zero response amplitude gives
the vernier threshold. Instant transformation of acquired VEP
data to VEP vernier acuity can be performed by in-house
software (Hou et al., 2018). VEP vernier threshold measurement
requires greater technical expertise to conduct compared to
psychophysical methods; detailed descriptions of methodology
are included in several studies (Norcia et al., 1999; Skoczenski
and Norcia, 1999; Hou et al., 2007). In normal as well as
amblyopic subjects, vernier acuity measurements made with VEP
demonstrate a 1:1 relationship with psychophysical methods of
measuring vernier acuity (Hou et al., 2018). VEP measurement
of vernier acuity is therefore a valid method that does not require
behavioural responses.
Following the COVID-19 pandemic and with rising pressures
on clinics for ophthalmic treatments, greater attention is being
given to the use of home monitoring to facilitate provision
of streamlined care (Jones et al., 2021; Ward et al., 2021).
Targeted vernier acuity tools can also be utilised, within the
clinic setting or even in a patient’s home, to monitor changes
in macular function, particularly important in diseases such as
age-related macular degeneration (AMD). Based on detecting
the pathological distortion of stimuli that occurs from retinal
elevation secondary to choroidal neovascularisation or drusen,
preferential hyperacuity perimetry (PHP) can localise and
quantify metamorphopsia (Alster et al., 2005). The Foresee PHP
(Notal Vision, Tel Aviv, Israel) and its newer home version,
ForeseeHome4, require the patient to fixate on a central cue
on a screen and view a succession of stimuli. Each stimulus
4www.foreseehome.com
consists of a dotted line (Figure 2C), of which some dots deviate
from the main axis of the line (an artificial distortion) (Alster
et al., 2005; Querques et al., 2011). The patient indicates, either
by touch or mouse cursor, where the perceived distortion is.
When a pathological distortion is perceived to be larger than
the artificial distortion, the patient will preferentially indicate the
pathological area. The size of the distortion is varied between
trials so that the degree of the pathological distortion can be
quantified. Self-monitoring on the ForeseeHome, now approved
by the United States Food and Drug Administration for AMD
patients at risk of vision loss from choroidal neovascularisation,
takes 3 min per eye and assesses the central 14 degrees of a
patient’s visual field. As it is a telemonitoring device, the data is
automatically sent to the prescribing retinal specialist for review.
Although PHP does not output a vernier threshold per se, it
utilises the principle of a psychophysical vernier task to identify
pathology (see section “Retinal Pathologies” for further details
and evidence for its use).
NEURO-OPHTHALMIC MECHANISMS
OF VERNIER ACUITY
Conventional visual acuity, as is usually measured during
assessment of visual conditions, relates to the ability of a viewer to
resolve two visual stimuli as separate, that is to discriminate their
spatial separation. Photoreceptors of the fovea have been shown
by microscopy to be arranged approximately in a hexagonal
mosaic, each receptor acting as a discrete unit (Westheimer,
2012). For the light from two visual stimuli to be resolved
or distinguished as separate, the intervening reduction in light
stimulus must be detected by a single receptor that is flanked by
two other receptors that receive a greater light signal (Figure 3).
Therefore, the resolution limit in the eye as measured by visual
acuity matches the spacing between photoreceptors. This forms
the basis of visual acuity and is exemplified by the ability to
distinguish optotype letters, e.g., “O” from “C” or “P” from “F.”
The optical resolution limit, or minimum angle of resolution,
corresponds to 1 arcminute of visual angle, or 2 mm when viewed
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FIGURE 3 | A comparison between the concepts of visual acuity and vernier
acuity using a hexagonal mosaic model of retinal photoreceptors. Yellow
circles with blurred edges represent areas of retinal illumination. Classical
visual acuity, or resolution acuity (R), involves resolving two stimuli as separate
and requires a gap in retinal illuminance to be detected by a photoreceptor
located between other photoreceptors receiving stimulation. Vernier acuity (V)
involves localisation of the difference in spatial positions of two separate
stimuli.
FIGURE 4 | Adaptation of Ewald Hering’s (1899) illustration to demonstrate
his eye-movement hypothesis for detection of a small vernier offset, using a
hexagonal retinal receptor mosaic model. Each receptor corresponds to an
all-or-none “local sign” or “space value.” (A) The offset edge lies along two
lines of receptors, with the top half exciting only line 2, and bottom half
exciting both lines 1 and 2. Excitation is depicted in green. (B) The offset edge
completely falls along a single line of receptors (line 2) and is therefore
perceived as “straight.” Small, repetitive eye movements between (A,B) would
provide the location difference of the offset lines via higher order averaging
(Strasburger et al., 2018). (C) In a different orientation, an offset edge lies
parallel to the boundaries between receptors. With minute horizontal eye
movements across the arrangement, receptors marked 1 and 2 contribute to
the location signal of the lower half, and receptors marked 2 and 3 contribute
to the location signal of the upper half, thus leading to differential excitation
along the edge. Note that on the retinal surface, the edge will not be so
sharply demarcated as in this figure; diffraction will result in a steep gradient of
illumination.
at 6 m. This is a well-studied concept and Westheimer (1987)
presents an in-depth description of the limits that diffraction
theory imposes on visual acuity. Despite this physical limit,
humans can recognise positional offsets of an order of magnitude
less than this. This begs the question of the basis of the ability to
detect locational differences of less than a cone diameter, beyond
the optical and anatomical limits of the eye.
The exact mechanism underlying the ability of vernier
acuity, and other hyperacuities, to surpass this resolution limit
of the eye and the retinal elements is still being clarified.
Hering (1899) proposed that neural averaging of the signals
of receptors along a target (the “local signs”), across minute
eye movements, could explain the ability to precisely localise
signals (Figure 4; Strasburger et al., 2018). However, as he
included the key concept regarding eye movements only in a
footnote to his paper, he became widely miscited as having
proposed that averaging occurred along the length of the line
contour, an idea that in time was disproved by experiments
showing that dot and curve stimuli could also act as vernier
stimuli. The role of averaging across eye movements was
independently put forth again by Andersen and Weymouth
(1923) in their ‘retinal mean local sign’ theory. Averill and
Weymouth (1925), upon discovering the neglected footnote,
subsequently reattributed the origin of this concept to Hering
but through their own experiments also contended for the roles
of length summation and binocular summation in building the
mean local sign. Further knowledge about receptive fields adds
to this understanding. V1 is made up of orientation sensitive
receptive fields. Both single cell and psychophysical recordings
support the sensitivity of hyperacuity threshold to orientation of
the target, pointing to the receptive fields being a key component
of the underlying mechanism (Swindale and Cynader, 1986;
Vogels and Orban, 1990; Fahle and Harris, 1998).
The development of more sensitive experimental techniques,
particularly for retinal image stabilisation, has provided further
support for the importance of small eye movements in both
hyperacuity and conventional visual acuity (Strasburger et al.,
2018). Averill and Weymouth (1925) measured a two-fold
reduction in vernier thresholds when stimulus exposure time
was reduced from 1540 to 30 ms, a time frame chosen to
restrict eye movement response, though they were only able
to partially control for differences in light flux with their
technology at the time. More sensitive methods by Westheimer
and McKee (1977a) with full equating of light flux across the
exposure period found vernier thresholds relatively unchanged
with exposure times as low as 11 ms, suggesting that eye
movements are not an absolute limiting factor for vernier acuity
(Westheimer, 2018).
Vernier acuity thresholds remain robust to movements
when the target is moving up to several degrees per second
(Westheimer and McKee, 1975). Performance is reduced if
the stimuli are shown asynchronously; even 20–50 ms apart
will impair the threshold. Like other visual functions, vernier
acuity shows an “oblique effect” where performance is reduced
for obliquely oriented stimuli, compared to those aligned with
vertical and horizontal meridians (Ludvigh and McKinnon,
1967). This is thought to result from increased positional
uncertainty resulting from lower cortical density of neurons
tuned to oblique orientations, or increased topographic noise
(Saarinen and Levi, 1995). Furthermore, vernier acuity is
susceptible to crowding (Westheimer and Hauske, 1975), where
masking or interference by nearby stimuli causes reduced
performance. This points to a cortical mechanism whereby
signals are aggregated and processed from a wider retinal area
than that indicated by the stimuli. Flanking lines produce the
greatest interference when placed at a distance of 2–4 arcmin
from the target stimuli (Levi et al., 1985). Therefore, for accurate
and reproducible measurement of vernier acuity it is best to
proceed without any crowding markers, while presenting the
stimuli synchronously, and ideally in horizontal or vertical
meridians. One study found that when obliquely oriented stimuli
were presented, participants would attempt to reorient their
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head, which would interfere with measurement accuracy (Schmid
et al., 2018). Overall, it appears from the evidence presented
that a cortical mechanism involving processing of ganglion
cell impulses, which themselves aggregate the output of many
photoreceptors, allows for fine thresholds in the hyperacuity
range to be distinguished.
Psychophysical methods, electroencephalography (EEG) and
cortical imaging have assisted to elucidate the nature of the
cortical mechanisms underlying vernier acuity. Both the primary
visual cortex (V1) and extrastriate cortical regions have been
implicated in the cortical processing of vernier stimuli. Hou
et al. (2017) carried out source imaging studies using functional
magnetic resonance imaging (MRI)-informed EEGs to localise
sources of vernier and grating acuity in four visual regions: V1,
lateral occipital cortex, hV4, and middle temporal cortex. V1
and lateral occipital cortex were the most sensitive cortical areas
to vernier displacement stimuli, providing further evidence that
detection of vernier acuity involves striate mechanisms. However,
grating stimuli (which reflects resolution limits) evoked equal
responses in all four regions. Later studies measuring vernier-
related activity with steady state VEPs showed a predominant
initial response over medial occipital electrodes, with broadly
distributed secondary responses occurring later that were
consistent with a feedforward pathway originating in the early
visual cortex and progressing to higher-order areas (Barzegaran
and Norcia, 2020). In contrast, VEPs for letter acuity showed a
dominant component over the lateral occipital areas, particularly
in the left hemisphere, with later responses at the early visual
areas due to feedback. The differences in cortical response
topography indicate that while the cortical sources of vernier and
letter acuity are distinct, they both undergo processing in the
early visual cortex.
Both visual and vernier acuity deteriorate in the periphery
compared to central vision. However, the rate at which this
happens differs between the 2 modalities, emphasising the
difference between these measures of acuity (Levi et al., 1985;
Virsu et al., 1987; Wilson, 1991). Whilst visual acuity is
restricted by retinal factors and ganglion cell receptive field size,
vernier acuity is limited by cortical factors including cortical
magnification. When the visual target is scaled to cortical
magnification at each eccentricity, vernier acuity performance
in the periphery is similar to at the fovea (Levi et al.,
1985). The relationship with cortical magnification explains
much of the variability between eccentricities, confirming that
vernier acuity is a result of higher-level processing. However,
cortical magnification does vary between individuals (Horton
and Hoyt, 1991). Levi et al. used “perceptive hypercolumns”
to describe the psychophysical processing modules of the
cortex that subtend a few minutes in the fovea, and found
vernier thresholds to be around 1/40th the size of a perceptive
hypercolumn. The presence of interfering stimuli within the
same or adjacent perceptive hypercolumn reduced vernier
performance (Levi et al., 1985). It should be noted that
ocular dominance columns, which each span a similar retinal
area to perceptive hypercolumns, were not found to be
the anatomical site of hyperacuity cortical processing, as
hyperacuity thresholds in the test eye were not affected by the
absence or presence of interlaced input from the other eye
(Westheimer, 1982).
The linear cortical magnification factor in V1, which reflects
the cortical spatial sampling of retinal neurons and varies by
retinal eccentricity, was measured using functional MRI and
demonstrated a correlation between cortical magnification and
vernier acuity within observers (Duncan and Boynton, 2003).
The computed cortical representation of vernier acuity thresholds
was approximately constant across all retinal eccentricities,
with a cortical distance of 0.12 mm representing the retinal
space occupied by the mean acuity threshold. Due to the
consistent cell density in V1, this suggests that a constant
number of neurons corresponds to the cortical representation
of the mean vernier acuity threshold. Observers with larger
overall cortical area in V1 had lower vernier acuity thresholds,
and greater changes in the cortical magnification factor with
retinal eccentricity were found in observers who also showed
greater changes in vernier acuity thresholds with retinal
eccentricity. Of the inter-individual variability in vernier acuity
thresholds between observers, 21–23% was attributed to cortical
topology differences.
Vernier acuity is resistant to contrast and luminance changes
at suprathreshold levels (Wehrhahn and Westheimer, 1990;
Waugh and Levi, 1993b), with detection reaching its optimum
level at a Michelson contrast of 0.22 when background luminance
is 860 cd/m2. An exponential increase in the vernier threshold
at contrast below 0.22 was found. In terms of decimal acuity,
vernier acuity is 10-fold that of visual acuity both under
photopic and scotopic conditions (Freundlieb et al., 2020).
Most studies in the literature test at a Weber contrast of
90% or above, or a Michelson contrast of 80% or above.
Studies investigating the relationship between target contrast and
target separation using vernier line targets suggest that vernier
acuity demonstrates contrast-dependent mechanisms when there
is a small separation (2 arcminutes or below) between the
targets, whereas larger separations (4 arcminutes or above) are
contrast-independent (Waugh and Levi, 1993a). This led to
the hypothesis that spatial filters that depend on contrast are
involved in the processing of close targets, but not of targets with
large separation.
As with other forms of acuity, vernier acuity is improved with
binocular summation (Banton and Levi, 1991). Interestingly,
when one eye is presented with masking stimuli, the fellow eye
will demonstrate elevated vernier thresholds (Mussap and Levi,
1995). This suggests there is an interaction in binocular function
beyond summation, and may be reflective of information
processing downstream from the initial cortical processing site.
Thus for accurate vernier acuity measurement, we recommend
each eye be tested monocularly, using a fully black occluder that
does not introduce interference to the tested eye.
Training can improve vernier task performance and does
not require feedback to be effective. A training schedule of
2000–2500 trials per individual resulted in a 40% reduction in
thresholds (McKee and Westheimer, 1978). This is analogous
to visual training for amblyopia and stroke. This may have
developed evolutionarily due to the role vernier acuity plays
in facial recognition, where it was demonstrated that vernier
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FIGURE 5 | Development of vernier acuity in early life. Adapted from Zanker et al. (1992).
acuity judgments made between eye and mouth positions assist
with facial discrimination in synthetic faces (Vesker and Wilson,
2012). Vernier acuity has also been found to play a role in visual
word processing. A Chinese study found that vernier acuity was
significantly correlated with improved Chinese character form-
matching task performance, implying a strong contribution to
an early stage of Chinese hierarchical word processing. Grating
acuity was not found to have such a correlation (Tan et al.,
2018). However, vernier acuity was found to be unaffected in
English-speaking subjects with dyslexia (Everatt et al., 1999).
This discrepancy in findings may be explained by a difference
between character-matching for Chinese characters and reading
English words, and the number of components that make up the
characters in the different languages. Vernier acuity likely plays a
role in other aspects of visual experience, but this has not yet been
explored in the literature.
VERNIER ACUITY OVER THE LIFESPAN
Vernier acuity appears to follow a steeper gradient of
improvement across childhood, with maturation likely to
occur at around age 6, with further fine-tuning continuing into
the teenage years (Figure 5). Earlier methods using preferential
looking demonstrated the development of vernier acuity from
before six months of age (Manny and Klein, 1984). The early
studies found vernier acuity to be poorer than grating acuity in
very early life but then superior to grating acuity at around 3
to 4 months, remaining so for the lifespan, a pattern also seen
in stereoscopic acuity, another type of hyperacuity (Shimojo
et al., 1984). Later studies with more accurate methods using
eye tracking with infrared technology, and stationary stimuli
to measure both vernier and grating acuity to remove motion
as a confounder, indicate that vernier acuity is worse or equal
to grating acuity until 4 years of age, at which time it becomes
significantly superior (Zanker et al., 1992; Skoczenski and Norcia,
1999). The age of maturity for vernier acuity varies from 6 to
14 years of age (Zanker et al., 1992; Kim et al., 2000). This pattern
of development provides support that this is a cortically driven
response, as increasing visual input provides opportunity for
increased developmental response.
Although early studies (Odom et al., 1989; Lakshminarayanan
et al., 1992; Whitaker et al., 1992) had concluded vernier acuity is
stable with age in adulthood, this was likely a result of a floor effect
when testing younger subjects due to large pixel sizes on screens.
Later studies utilising smaller pixel size on higher resolution
displays, and therefore enabling a smaller step-size for the vernier
offsets, demonstrated that vernier acuity indeed does worsen with
age – by about a factor of two above age 60 (Li et al., 2000; Garcia-
Suarez et al., 2004). Electrophysiological studies measuring visual
evoked potentials confirmed both increased vernier thresholds
with age and time required to process vernier stimuli (Li et al.,
2001). One suggestion for this effect is a reduction in sampling
efficiency with age in the visual cortex due to neuronal changes
(Li et al., 2012). This relationship may be disadvantageous for
some proposed uses where age may be a confounder, such as for
determining potential visual acuity prior to cataract surgery or in
long-term studies.
CURRENT CLINICAL UTILITY AND
POTENTIAL APPLICATIONS
Cataract
Vernier acuity is an indicator of neural visual function. It is
highly resistant to retinal image degradation up to a certain
point, as well as robust to variations in contrast and luminance,
making it an ideal candidate to study neural visual potential
in cataract patients (Williams et al., 1984). Conventional visual
acuity does not distinguish visual loss due to optical media
factors from that caused by retinal or neural factors, and
thus may lead to disappointing results post-operatively. In the
Frontiers in Neuroscience | www.frontiersin.org 6 October 2021 | Volume 15 | Article 714843
fnins-15-714843 September 29, 2021 Time: 16:54 # 7
Hu et al. The Clinical Use of Vernier Acuity
FIGURE 6 | Examples of hyperacuity gap test and hyperacuity perimetry curves from case studies by Essock et al. (1985) to discriminate visual loss due to cataract
from that due to retinal pathology. The gap test curve (top) from a subject can be compared to a set of measured curves from patients with cataract resulting in
varying levels of visual acuity loss. The hyperacuity perimetry curve in normal vision (bottom, dashed line) is characterised by a central sensitivity peak at the fovea,
with flattening (or reversal) of this peak indicating impaired macular function.
presence of simulated cataracts by viewing through ground
glass, vernier acuity was found to be more resistant to image
degradation than resolutional acuity (Williams et al., 1984).
This finding was supported on examining patients with real
cataracts (Essock et al., 1984). In a series of cases studies, Essock
et al. (1985) compared the performance of two vernier acuity
tests in differentiating between retinal and optical causes of
visual loss (Figure 6). Firstly, they employed a “hyperacuity
gap test” that measured vernier thresholds across varying gaps
separating dot stimuli. Normally plotting vernier acuity on a
log scale against the gap size will produce an inverted U-shape
curve, as vernier acuity with dot stimuli is compromised with
very large (>6 arcseconds) or very small gap (<2 arcseconds)
sizes (Westheimer and McKee, 1977b; Essock et al., 1984). In
a normal observer, this curve is shallow with an optimum gap
size of 2–4 arcseconds. The characteristics of the curve change
with increasing levels of optical degradation from cataract or
simulated opacity (ground glass): the optimum gap size (curve
peak) increases, overall vernier performance is reduced, and the
curve steepness increases (Essock et al., 1985). The case studies
demonstrated that the gap test functioned as an indicator of
optical quality while being insensitive to retinal dysfunction, and
could predict what level of visual acuity loss was accounted for by
optical degradation alone. Secondly, they employed a hyperacuity
perimetry test that measured vernier performance across retinal
eccentricities, which provided information on macular function
while being resistant to effects of even severe optical opacities.
By comparing the resultant curves from these two tests to a
database of curves from patients with normal function or from
patients with cataract resulting in varying levels of visual acuity
loss (but no other visual condition), they were able to predict
whether patients’ reduced visual function was likely primarily
due to retinal or optical pathology (Essock et al., 1984). This
thus illustrates the utility of this battery of vernier tasks for
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assessment prior to cataract surgery to predict potential for
visual improvement.
Retinal Pathologies
The PHP (see section “Measurement of Vernier Acuity”)
devices are now FDA-approved to monitor for choroidal
neovascularisation in age-related macular degeneration (AMD).
The Home Monitoring of the Eye (HOME) study was a
controlled, randomised clinical trial comparing ForeseeHome
use with standard care in 1520 AMD patients (AREDS Home
Study Research Group et al., 2014). It demonstrated earlier
choroidal neovascularisation detection in patients randomised
to home-based device monitoring than in controls, highlighting
an important role for vernier acuity in initiating early anti-
angiogenic therapy to maximise visual outcomes. A meta-
analysis demonstrated a superior pooled sensitivity of PHP (0.85)
compared to the Amsler grid (0.78) for screening for the presence
of neovascular AMD, although the specificity of PHP (0.87) was
lower than that of the Amsler grid (0.97) (Faes et al., 2014).
While the current clinical standard for screening for AMD
progression is the Amsler grid, it has demonstrated poor efficacy
in identifying sight threatening pathology (Fine et al., 1986;
Schwartz and Loewenstein, 2015); therefore PHP, with its higher
sensitivity, may help improve outcomes for AMD patients despite
its lower specificity.
Furthermore, PHP is also useful for monitoring response to
anti-angiogenic therapy in neovascular AMD. In a prospective
study in 14 AMD patients undergoing a single ranibizumab
injection, improvement in Foresee PHP test performance was
closely correlated with improvement in macular morphology as
measured on spectral domain optical coherence tomography,
as well as improvement in best corrected visual acuity
(Querques et al., 2011).
Alternative self-monitoring tests using vernier acuity have
shown promise for screening for neovascular AMD. An iPad-
based Hyperacuity App, which requires the user to complete a
task similar to that of the PHP, demonstrated 0.923 sensitivity
and 0.615 specificity in identifying choroidal neovascularisation
in AMD patients (Chen and Adelman, 2016). Preliminary
data from a case-control study on a computer-based Vernier
hyperacuity alignment task in diagnosing wet AMD showed 0.75
sensitivity and 0.94 specificity (Schmid et al., 2018). Reduced PHP
performance has also been shown in other retinal pathologies
such as polypoidal choroidal vasculopathy (Kim et al., 2014)
and hydroxychloroquine retinal toxicity (Anderson et al., 2009).
Recent work has shown hydroxychloroquine toxicity to be
more common than realised (Yusuf et al., 2021) and as such,
a screening tool for home monitoring may be of use for
early identification of toxicity to reduce disease burden and
improve patient outcomes. It is feasible that PHP would be
useful to monitor metamorphopsia in other retinal pathologies
such as Stargardt disease, but this has not been reported
in the literature.
In retinitis pigmentosa, vernier acuity is reduced to a
similar degree as letter acuity and grating acuity, suggesting
that increased foveal inter-cone spacing is responsible for the
reductions in these types of acuities, requiring larger stimulus
dimensions in order to perform these tasks to account for the
increased grain size of the retinal mosaic (Alexander et al., 1992).
Glaucoma
Vernier acuity has been investigated as a proxy measure for the
change in receptive fields due to ganglion cell loss in glaucoma.
Piltz et al. (1993) and McKendrick et al. (2002) found vernier
acuity to be an earlier marker than conventional visual acuity
or visual field loss, which would indeed support this hypothesis.
Mean vernier thresholds were increased by 64% in glaucomatous
eyes and 47% in suspect eyes; however, there was significant
overlap between the groups (Piltz et al., 1993). A similar pattern
was found by McKendrick et al., and additional testing at
varying contrast levels did not provide additional sensitivity.
This would suggest that vernier acuity would be most helpful
in situations where baseline results are available and relative
change can be assessed.
Amblyopia
Amblyopia is a visual disorder resulting from cortical suppression
of visual input from one eye during a critical developmental
period in early life. It can be caused by strabismus, anisometropia
or visual deprivation. Many visual functions are found to be
impaired in amblyopic eyes, such as contrast sensitivity, spatial
integration (e.g., contour integration and global orientation
discrimination), global motion perception, motion-defined form
perception, and stereopsis (Wong, 2012). These abnormalities in
visual function, and even in more complex cognitive functions,
result from dysfunction spanning various areas, including of
early processing in V1 and higher level processing in extrastriate
areas (Wong, 2012). In unilateral amblyopia, vernier acuity
performance is reduced in the amblyopic eye but the fellow eye
does not show deficiency, which is in contrast to other tasks
involving contrast sensitivity or spatial integration (Meier and
Giaschi, 2017). This is a result of the cortical suppression for
spatial information corresponding to the amblyopic eye, which
leads to spatial distortions and spatial uncertainty. Therefore,
an elevated vernier acuity threshold may alert a clinician to
neurological or developmental abnormalities so that further
investigation or referrals can be undertaken.
Visual evoked potentials measurements in amblyopic patients
show a proportional reduction in both vernier acuity and letter
acuity (Hou et al., 2018). As both depend on retinal eccentricity,
with steep reductions at greater eccentricity from the fovea,
this linkage may be explained by the reduced central visual
function in amblyopia that occurs secondary to the loss of
high-spatial frequency receptive fields and abnormal binocular
inhibitory interaction. Vernier performance in the amblyopic eye
is more disrupted in strabismic amblyopes than in anisometropic
amblyopes, an effect that is greatly magnified when presenting
vernier stimuli of high spatial frequency (Levi and Klein, 1982),
alluding to differing underlying neural adaptations occurring
in these two forms of amblyopia (Meier and Giaschi, 2017).
Anisometropic amblyopia is associated with global spatial
suppression, whereas strabismic amblyopia causes more localised
suppression of the cortical regions that correspond to retinal
areas that do not fuse due to the squint. In demonstration of
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neural plasticity, vernier acuity in the amblyopic eye can be
improved with occlusion therapy in children and with practice of
vernier tasks in adults (Levi et al., 1997; Meier and Giaschi, 2017).
Perceptual learning from the amblyopic eye due to repetitive
practice can even transfer to the fellow eye (Li et al., 2008).
Using both VEP and psychophysical measurements in
amblyopic patients, vernier acuity has been found to be a more
accurate marker of letter acuity loss than grating acuity (Hou
et al., 2018). Hence, vernier acuity may be a more reliable method
of identifying or monitoring amblyopia than grating acuity,
particularly in pre-verbal subjects.
Consistent with the vital role of cortical processing in vernier
tasks, children with cortical visual impairment (bilateral visual
impairment resulting from perinatal insult to the visual cortex
or optic radiations) demonstrate a more severe deficit in vernier
acuity compared to grating acuity (Skoczenski and Good, 2004).
Other Conditions
Vernier acuity has been investigated in a number of other
conditions. Vernier thresholds have been found to be elevated
in Down syndrome by a factor of 2.7, indicating that impaired
cortical processing contributes to poor optical quality in causing
reduced visual function (Little et al., 2009).
Vernier acuity, a measure of V1 performance, is unchanged
in migraine patients, indicating that the deficit in global form
and motion processing in these patients is not mediated through
impaired V1 processing (McKendrick et al., 2006).
Vernier acuity can also be used to assess early stage neural
processing performance in other visual pathways. Vernier tasks
using specific stimuli such as low contrast or isoluminant
blue-yellow coloured objects have been employed to study
differences in magnocellular (M) and parvocellular (P) visual
pathway functions in patients with psychiatric conditions.
Subjects with untreated schizophrenia demonstrated dysfunction
in vernier tasks involving stimuli specific to the M pathway
(Keri et al., 2004), while subjects with bipolar disorder
demonstrated impaired M and P pathway functions only during
a depressive state (Keri et al., 2007). Psychophysical studies in
conjunction with physiological studies in macaque parafoveal
ganglion cells have lent support to a hypothesis that M and
P pathways have access to spatial position information used
by vernier acuity mechanisms (Sun et al., 2012). It has been
argued that vernier acuity itself, however, is not an accurate
representation of magnocellular sensitivity as conditions that
do not cause magnocellular deficits can caused reduced vernier
acuity (Skottun and Skoyles, 2010).
BARRIERS TO CLINICAL USE
Although vernier acuity or hyperacuity has been proposed and
tested as a diagnostic aid for various ophthalmic conditions,
including AMD, amblyopia and glaucoma, it has met with several
barriers. The measurement process can be time consuming,
requiring many trials to measure mean vernier threshold due
to interindividual variability. A study using the method of
adjustment required a minimum of 100 to 700 trials to achieve
a mean precision of 10% (Abbud and Cruz, 2002). Ten trials were
reported to take about 5 min, implying 100 trials would require
50 min. Another study using a staircase method to investigate
the effect of positional noise on vernier acuity across age groups,
including in elderly subjects, required 60–90 min of measurement
time across 1 to 2 sessions to record 400 responses per participant
(100 responses each at 4 noise levels) (Li et al., 2012). This
necessitates balancing the need for a more accurate result against
the practicalities of conducting the test within a time period
appropriate for participant concentration, as fatigue will also
reduce measurement accuracy. The long attention span required
for such a task has been suggested as a reason for the higher
thresholds in children (Abbud and Cruz, 2002). Furthermore,
training changes performance due to cortical plasticity. Where
training is incorporated into a study, the results cannot be
compared to naïve observers.
Despite the availability of free tools to measure vernier acuity
on common equipment such as desktop or mobile computers,
vernier acuity is not in widespread clinical use for assessing visual
function and is not well understood in the clinical community.
The development of commercially available vernier acuity-based
tools with clinical utility in AMD allows for the standardisation
of testing across research groups and clinical settings, making
vernier acuity more accessible. In addition, standardised tools
allow validation of these methods to help us better understand
the utility of this technique and expected normative values.
BEST PRACTICE GUIDANCE FOR
VERNIER ACUITY
Psychophysical Measurement
In order to provide the most reproducible results we recommend
to:
• Use one of the available software test suites which have
optimised the staircase paradigms:
◦ Freiburg Acuity Test (FrACT) software (see footnote 1).
◦ Psychophysics Toolbox (see footnote 2).
◦ Psychopy (see footnote 3).
• Test without crowding markers.
• Use a gap size of 4 arcminutes for optimum vernier
threshold measurement (Westheimer and McKee, 1977b).
• Present the stimuli synchronously.
• Present the stimuli in horizontal or vertical meridians
rather than oblique.
• Use high contrast levels of over 90%.
• Test monocularly using a black occluder over the eye not
being tested to avoid binocular interference.
VEP Measurement
• Sweep VEP method (Almoqbel et al., 2008).
• Square wave grating containing a vernier offset and at a
Michelson contrast of 80% (Chen et al., 2005).
• ISCEV standard electrode placement for 3 channel VEPs
appear to be sufficient (Hou et al., 2007, 2018).
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• Use of asymmetric stimuli, such as pattern onset-offset VEP
stimuli (Hou et al., 2017).
• Use of multiple luminance levels.
• Use of the first harmonic for threshold determination.
Discrete Fourier analysis applied to the amplitude and
phase, ensuring the SNR is ≥3:1 with the phase of
the response reaming constant or gradually lagging the
stimulus as spatial frequency increases (Skoczenski and
Norcia, 1999; Watson et al., 2009).
CONCLUSION
Vernier acuity, the archetypal hyperacuity, demonstrates the
remarkable ability of cortical processing in the visual system to
discriminate small offsets between stimuli at a level surpassing
the resolution limits of the retina. This provides a measure that is
complementary to the measurement of visual acuity by providing
information about a different process along the visual pathway.
A wide variety of tools that range in complexity have emerged
to measure vernier acuity, with some now in clinical use for the
monitoring of macular disease. Investigating vernier acuity as
a marker of retinal or cortical function has use in ophthalmic
diagnostics, as well as a marker of therapeutic success.
The clinical use of vernier acuity has been limited to date
by a poor understanding of the technique by clinicians, and
limited accessibility to equipment to facilitate testing. However,
the availability of open access software (such as the FrACT) now
opens the door for increased uptake of this useful test.
To provide more evidence for the clinical implementation
of vernier acuity, there are a number of unanswered questions.
Further investigations into the use of EEG estimations of vernier
acuity (for non-verbal patients) are warranted. PHP could be
a beneficial monitoring tool for retinal disease affecting the
macula, such as Stargardt disease and bull’s eye maculopathy
during hydroxychloroquine intake; longitudinal studies of this
tool would be of interest.
Vernier acuity is a useful tool in the diagnosis and
management of neuro-ophthalmic disorders. Development of
commercial products, such as ForeseeHome, indicate a likelihood
of increased uptake in clinical care in the future.
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